Valbenazine
A novel, highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor; is approved for the treatment of tardive dyskinesia.
Product Specifications
CAS Number
1025504-45-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
418.5695
Molecular Formula
C24H38N2O4
Notes
Research use only, not for human use.
Receptor
Other Targets
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog